Avnet, Inc. — Form 10-Q Summary
Reporting period: Fiscal third quarter ended March 30, 2024, with nine-month results also reported. Although the request metadata says “2023 Q3,” this filing covers fiscal Q3 2024; comparisons are with the quarter and nine months ended April 1, 2023. Figures below are in U.S. dollars.
Financial performance
| Metric | Q3 FY2024 | Q3 FY2023 | Nine months FY2024 | Nine months FY2023 |
|---|---|---|---|---|
| Sales | $5.654B | $6.515B | $18.194B | $19.982B |
| Gross profit | $669.3M | $811.8M | $2.124B | $2.364B |
| Gross margin | 11.8% | 12.5% | 11.7% | 11.8% |
| Operating income | $190.2M | $313.6M | $680.2M | $903.1M |
| Operating margin | 3.4% | 4.8% | 3.7% | 4.5% |
| Net income | $88.8M | $187.4M | $416.0M | $615.6M |
| Diluted EPS | $0.97 | $2.03 | $4.52 | $6.58 |
- Quarterly sales fell 13.2%; nine-month sales fell 9.0%. Management attributed the decline mainly to the electronic-components market downturn, elevated customer inventories, lower demand, and, to a lesser extent, lower-priced product mix.
- Quarterly operating income declined 39.4%. Lower gross profit and reduced operating leverage were primary drivers; restructuring and integration costs also weighed on results.
- Interest and other financing expense was $73.5M for the quarter and $218.6M for nine months, up from $71.7M and $175.8M, respectively, primarily due to higher borrowings and borrowing rates. Nine-month results included an $86.5M gain on legal settlements, versus $61.7M a year earlier.
Cash flow, balance sheet, and liquidity
- Nine-month operating cash flow was $415.7M, versus cash used of $948.2M in the prior-year period. Management cited improved working-capital cash use, particularly inventory; cash used for working capital and other was $152.6M versus $1.70B. The MD&A separately reports $499M of operating cash flow for Q3.
- Nine-month investing cash outflow was $199.6M, including $200.2M of capital expenditures, up $62.4M year over year, primarily for EMEA distribution-center investments. Financing cash outflow was $284.5M; the company reported net debt repayments of $106.3M, dividends of $84.2M, and share repurchases of $86.0M.
- At March 30, 2024, cash was $218.5M, down from $288.2M at July 1, 2023. Current assets were $10.49B and current liabilities $4.49B. Inventory was $5.75B, up from $5.47B at fiscal year-end.
- Total debt was approximately $2.95B at quarter-end, compared with $3.06B at July 1, 2023; $548.5M was classified short-term and $2.406B long-term. The filing notes that $475.7M was outstanding under the accounts-receivable securitization program, which is due December 2024.
- Combined borrowing capacity under the credit facility and securitization program was $2.20B, with approximately $889.7M of committed availability. The company reported compliance with applicable covenants. Management believes operating cash generation and available borrowing capacity will meet future liquidity needs.
Outlook, management commentary, and risks
- Management expected Q4 FY2024 sales to be 3%–8% below Q3, with a corresponding negative effect on operating income and diluted EPS. The downturn’s duration was described as uncertain; management cited possible sequential growth in Asia and increased IP&E orders in EMEA and Farnell as encouraging signs.
- Cost-reduction actions were underway: Farnell initiatives were expected to deliver $50M–$70M in annual benefits, with additional EC and corporate initiatives expected to yield $40M–$60M. About half the planned annual reductions had been completed by quarter-end; remaining actions were expected by fiscal year-end. Incremental Q4 restructuring, integration, and other expenses were expected at a level similar to Q3.
- Fiscal 2024 restructuring actions involved the reduction or planned reduction of approximately 400 employees. The company recorded $11.8M of restructuring, integration, and other expenses in Q3 and $24.1M for nine months; the quarter also included a $5.5M reduction in environmental remediation reserves.
- Legal and compliance matters remain subject to uncertainty. Management did not expect them to materially affect financial position or liquidity, but some could be material to results in a single period. Estimated liabilities for reasonably estimable compliance matters were $17.2M at March 30, 2024.
- Key disclosed risks include industry cyclicality and semiconductor demand, supplier relationships and product allocations, customer credit, foreign exchange and international operations, cybersecurity and systems, supply-chain disruption, and general economic conditions. No material changes to the annual-report risk factors were reported.
Important facts for investors to verify
- Whether demand and customer inventory levels are improving, and whether Q4 sales fall within management’s 3%–8% sequential-decline outlook.
- Progress and realized savings from the announced cost reductions, including the associated restructuring costs.
- Inventory levels, working-capital cash generation, and the availability of eligible receivables supporting securitization borrowings.
- Debt maturities and refinancing needs, particularly the $475.7M securitization balance due December 2024, as well as interest-rate exposure.
- The sustainability of earnings excluding legal-settlement gains and the effects of tax-rate changes, foreign exchange, and environmental or compliance contingencies.